COMMUNIQUÉS West-GlobeNewswire

Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

16/04/2025 - 14:00

Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to address multiple indications across a range of cancer types Continued progress of lead program, AKTX-101, for the treatment of solid [...]

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025

16/04/2025 - 14:00

SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results [...]

electroCore to Participate at the Planet MicroCap Showcase

16/04/2025 - 14:00

ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Planet [...]

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

16/04/2025 - 14:00

BOTHELL, Wash., April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc . (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest (LSINW) [...]

Patent Granted to BC3 Technologies for SEAL Hemostatic Wound Spray

16/04/2025 - 14:00

-- FDA-Cleared Aerosolized Chitosan Hemostatic Agent Receives Patent for its Innovative Material and Method -- BALTIMORE, April 16, 2025 (GLOBE NEWSWIRE) -- BC3 Technologies, a Baltimore-based, minority-owned company [...]

OncoC4 Selected to Present at the 2025 AACR Meeting's Showcase Session

16/04/2025 - 14:00

Oral presentation will feature AI-081, a potentially best-in-class PD-1/VEGF bispecific antibody and ONC-841, a first-in-class anti-Siglec-10 antibody Initial clinical data for both AI-081 and ONC-841 in solid tumors [...]

MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30

16/04/2025 - 14:00

MARIETTA, Ga., April 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March [...]

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board

16/04/2025 - 14:00

Decoy’s development of novel peptide-conjugate therapeutics arising from its proprietary IMP3ACT™ platform to benefit from Dr. Langer’s extensive scientific knowledge and experience CAMBRIDGE, Mass. and HOUSTON, April [...]

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled

16/04/2025 - 14:00

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one of very few [...]

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting

16/04/2025 - 14:00

Update on American Association for Cancer Research Annual Meeting 2025 presentation PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a [...]

Prime Biome (Updated 2025): A Comprehensive Review of the Groundbreaking Skin-Gut Axis Supplement

16/04/2025 - 08:44

Clinically Inspired Gut-Skin Axis Supplement Prime Biome Faces Real Consumer Feedback and Scientific Scrutiny—Here’s What the Data and Verified Users Reveal in 2025 ST. PETERSBURG, Fla., April 16, 2025 (GLOBE NEWSWIRE [...]

Glutathione Tablets: RediClinic Offers 20% Off on Pure Japanese Glutathione Tablets for Skin Whitening

16/04/2025 - 08:58

New York, April 15, 2025 (GLOBE NEWSWIRE) -- Glutathione Tablets: RediClinic Offers 20% Off on Pure Japanese Glutathione Tablets for Skin Whitening Rediclinic glutathione tablets Content promoted by Branding Ex solution [...]

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME

16/04/2025 - 10:34

RECORDATI: FDA GRANTS ISTURISA ® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME ISTURISA ® is a cortisol synthesis inhibitor that blocks the [...]

Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l’exercice 2025

16/04/2025 - 06:57

Croissance des ventes de 11,6% à taux de change constant 1 , ou 11,7% en données publiées, tirée par toutes les aires thérapeutiques, incluant une contribution croissante d'Iqirvo et de Bylvay. Soumission réglementaire [...]

Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance

16/04/2025 - 06:57

Total sales growth of 11.6% at CER 1 , or 11.7% as reported, driven by all three therapeutic areas and including an increasing contribution from Iqirvo and Bylvay. Tovorafenib regulatory submission to EMA 2 for [...]

Higher cantonal composition authority approved the amendments to the terms of the 2025 convertible bond

16/04/2025 - 07:00

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – April 16, 2025 Idorsia Ltd (SIX: IDIA) today announced that the hearing by the higher cantonal composition authority ( obere kantonale Nachlassbehörde [...]

Santhera shares updates on commercial rollout of AGAMREE®

16/04/2025 - 07:00

Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding from [...]

Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025

16/04/2025 - 07:15

Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]

Émission Conditionnelle d’Actions

16/04/2025 - 08:00

INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Émission Conditionnelle d’Actions Mont-Saint-Guibert, Belgique – le 16 avril 2025, 8:00h CET / 2:00h ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” ou la “ [...]